Advertisement

Topics

Latest "Carlsson Research AB" News Stories

06:58 EDT 25th April 2018 | BioPortfolio

Here are the most relevant search results for "Carlsson Research AB" found in our extensive news archives from over 250 global news sources.

More Information about Carlsson Research AB on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Carlsson Research AB for you to read. Along with our medical data and news we also list Carlsson Research AB Clinical Trials, which are updated daily. BioPortfolio also has a large database of Carlsson Research AB Companies for you to search.

Showing "Carlsson Research" News Articles 1–25 of 24,000+

Wednesday 25th April 2018

Research shows possible new target for immunotherapy for solid tumours

Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumours. This study, being published in the April 24 advance online edition of the journal Science Signaling,...


Organoids in cancer research

AstraZeneca phase III ARCTIC trial of Imfinzi in combo with remelimumab in patients with PD─L1 low/negative NSCLC fails to meet primary endpoints

AstraZeneca and MedImmune, its global biologics research and development arm, announced high─level results from the phase III ARCTIC trial in patients with locally─advanced or metastatic non─small


Sarah Cannon Development Innovations Collaborates with Pivotal on Immuno-Oncology Trials

New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers Collaboration will enable patients in Europe to access novel investigational cancer therapies Sarah Cannon Development Innovations announced today a new strategic collaboration with Pivotal to expand a...

eClinical App, TrialKit, Gains More Advanced Features in Latest iOS Update

Research professionals now have access to enhanced capabilities, such as adjudication and risk-based monitoring, on mobile devices with Crucial Data Solutions' most recent update for TrialKit on iOS. RENO and TAHOE, Nev. (PRWEB) April 25, 2018 Crucial Data Solutions, Inc. announced today the latest update to TrialKit, an electronic data capture (EDC) mobile app for clinical trial management. ...

Fidia Announces Presentation of New Data Evaluating HYMOVIS® Effects on Cartilage Volume and Type II Collagen Turnover at Osteoarthritis Research Society International (OARSI) World Congress Meeting

Poster Title: “Hyaluronan Derivative Hymovis® Increases Cartilage Volume and Type II Collagen Turnover in Osteoarthritis Knee: Data from MOKHA (MRI, BiOmarkers, Knee, Hymovis®, OsteoArthritis) Study” Fidia Farmaceutici, a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products and its wholly ...

Relocation reflects ambitious growth plans

Ingenza is pleased to announce its relocation to Roslin Innovation Centre, a £30 million, multi-purpose research hub on the University of Edinburgh’s Easter Bush Campus. The centre offers 41,000 sq ft of flexible laboratory and office space, and Ingenza will occupy 11,000 sq ft on the top floor, with its own secure access to ensure security and confidentiality.

Cell Yourself Right & Get A Biotech Job

Hello biotechnologists, Update your Linkedin and cell yourself to one of these cool biotechs and start your new job! Check out the position in cell culture research at Axxam or become a brand manager for rheumatology at Lilly. Just starting out? Check out the ... This awesome article Cell Yourself Right & Get A Biotech Job appeared first on Labiotech.eu. Be kind and don't copy it without ...

First Derm® Releases First Artificial Intelligence Dermatology API

Skin Image Search™ to Help Identify Any Skin Concern with a Smartphone SAN FRANCISCO (PRWEB) April 25, 2018 First Derm® launches its Artificial Intelligence (AI) API to help assess any skin concern within a second. The FREE Skin Image Search™ uses the API and is in beta and will be improved on a monthly basis, by continuously training a deep Convolutional Neural Network (CNN) with skin d...

‘President and MPs, bring leadership to malaria fight’ – New Vision

New Vision'President and MPs, bring leadership to malaria fight'New VisionMalaria elimination is an important step on the path to achieving a middle income economy in Uganda. Malaria 703x422. Malaria elimination is an important step on the path to achieving a middle income economy in Uganda. OPINION By Chrispus Mayora In ...The clock is ticking on malariaEURACTIVTime for EU to take charge of globa...

DBV Technologies SA DBV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryDBV Technologies SA DBV is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets noninvasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform is an electrostatic patch that provides a suitable, selfadministered and noninvasive immunotherapy to p...

A common prebiotic may alter the obese microbiome and protect against osteoarthritis

Bacteria in the gut may be the culprit behind osteoarthritis and joint pain that affects people who are obese, according to research in JCI Insight. We know that osteoarthritis is a common side effect of obesity and this is often believed to be a consequence of the stress on joints. Now a group has found […] The post A common prebiotic may alter the obese microbiome and protect against osteo...

Tuesday 24th April 2018

Hospital patients are more interested in tracking their health data, research shows

New research shows that patients in the hospital are eager to collaborate with clinicians to track their health data.

Global Polyalkylene Glycol Market 20182022 [Report Updated: 07032018] Prices from USD $3500

This market research report presents a comprehensive analysis of the global polyalkylene glycol market by product polypropylene glycol and polyethylene glycol and by application PU foams, lubricants, personal care, pharmaceuticals, and others. The report also provides a comprehensive analysis of the growth opportunities for companies in this market in regions such as the Americas, APAC, and EMEA.T...

The US Oncology Network Strategic SWOT Analysis Review [Report Updated: 22032018] Prices from USD $125

The US Oncology Network Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your busi...

Experimental drug for rheumatoid arthritis prevents side effect of stem cell transplants

An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows.

Regular soaking in hot tub improves health outlook in obese women with PCOS

According to new research, obese women with polycystic ovary syndrome may be able to improve their health outlook with a particularly enjoyable form of therapy: regular sessions in a hot tub.

Wound Care Advantage (WCA) Launches Advanced Discovery Research Alliance to Revolutionize Patient Care Through Evidence-Based Science

WCA, in partnership with Dr. David G. Armstrong and the Southwestern Academic Limb Salvage Alliance (SALSA), brings together an international network of advanced wound centers for investigative research Wound Care Advantage (WCA), in collaboratio

Prana Biotechnology Ltd PBT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryPrana Biotechnology Ltd Prana Biotech is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer, and other major agerelated degenerative disorders. It is developing firstinclass therapies for the treatment of neurodegenerative disease. Prana Biotech develops technology platform in association with various institutions ...

Nicox: :Opening of U.S. Development Office in Research Triangle Park, North Carolina

Press Release Nicox: Opening of U.S. Development Office in Research Triangle Park, North Carolina Company to relocate its growing U.S. development operations to the North Carolina biotech hub in Research Triangle Park Nicox Research Triangle Park team strengthens and expands Nicox's development capabilities, with a focus on advancing NCX 470 and NCX 4251 .........................

Indiana University Research Technology Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12032018] Prices from USD $250

SummaryIndiana University Research Technology Corp IURTC, a subsidiary of Indiana University is a notforprofit agency that handles intellectual property, trademarks, and business development activities. The agency offers solutions such as technology commercialization, which include disclosure, marketing, legal protection and evaluation of research discoveries; and software licensing. IURTC provid...

Kaesong Complex A Starting Point For Two Koreas' Healthcare Cooperation?

As political talks gain momentum, the Kaesong Industrial Complex in North Korea could be the starting point of possible healthcare...   

CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research

Deal Watch Asia Focus: Pfenex Licenses Asian Rights To Forteo Copy To NT Pharma Group

Otsuka obtains Japanese rights to two cancer gene therapy candidates from Takara. GlaxoSmithKline extends its protein degradation collaboration with Kymera.  

Study highlights potential of stem cells derived from adults in regenerative medicine

Donor age does not appear to influence the functionality of stem cells derived from adult body tissues, concludes a new review. The analysis of research on induced pluripotent stem cells (iPSCs) finds that not only are typical signs of aging reversed in iPSCs, but cells derived from both older and younger donors show the same ability to differentiate into mature body cells.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks